vs

Side-by-side financial comparison of Bolt Biotherapeutics, Inc. (BOLT) and Medalist Diversified REIT, Inc. (MDRR). Click either name above to swap in a different company.

Medalist Diversified REIT, Inc. is the larger business by last-quarter revenue ($2.8M vs $2.5M, roughly 1.1× Bolt Biotherapeutics, Inc.). Medalist Diversified REIT, Inc. runs the higher net margin — -18.8% vs -265.2%, a 246.5% gap on every dollar of revenue. Over the past eight quarters, Medalist Diversified REIT, Inc.'s revenue compounded faster (4.8% CAGR vs -31.2%).

Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.

Medalist Diversified REIT, Inc. is a publicly traded real estate investment trust focused on owning, operating, and acquiring income-generating multi-family residential properties. Its portfolio is concentrated in high-growth US Southeast and Mid-Atlantic markets, targeting stable long-term returns for shareholders via rental income and property appreciation.

BOLT vs MDRR — Head-to-Head

Bigger by revenue
MDRR
MDRR
1.1× larger
MDRR
$2.8M
$2.5M
BOLT
Higher net margin
MDRR
MDRR
246.5% more per $
MDRR
-18.8%
-265.2%
BOLT
Faster 2-yr revenue CAGR
MDRR
MDRR
Annualised
MDRR
4.8%
-31.2%
BOLT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOLT
BOLT
MDRR
MDRR
Revenue
$2.5M
$2.8M
Net Profit
$-6.6M
$-529.6K
Gross Margin
Operating Margin
-283.4%
14.8%
Net Margin
-265.2%
-18.8%
Revenue YoY
11.8%
Net Profit YoY
58.4%
-88.4%
EPS (diluted)
$-9.38
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOLT
BOLT
MDRR
MDRR
Q4 25
$2.5M
$2.8M
Q3 25
$2.2M
$2.8M
Q2 25
$1.8M
$2.5M
Q1 25
$1.2M
$2.3M
Q4 24
$0
$2.5M
Q3 24
$1.1M
$2.3M
Q2 24
$1.3M
$2.3M
Q1 24
$5.3M
$2.6M
Net Profit
BOLT
BOLT
MDRR
MDRR
Q4 25
$-6.6M
$-529.6K
Q3 25
$-7.1M
$-395.9K
Q2 25
$-8.6M
$-456.4K
Q1 25
$-11.0M
$-1.0M
Q4 24
$-15.9M
$-281.2K
Q3 24
$-15.2M
$-527.0K
Q2 24
$-21.2M
$-521.7K
Q1 24
$-10.8M
$1.4M
Operating Margin
BOLT
BOLT
MDRR
MDRR
Q4 25
-283.4%
14.8%
Q3 25
-355.1%
15.8%
Q2 25
-510.5%
9.8%
Q1 25
-991.4%
-23.8%
Q4 24
17.7%
Q3 24
-1441.1%
13.0%
Q2 24
-1772.3%
9.4%
Q1 24
-324.1%
Net Margin
BOLT
BOLT
MDRR
MDRR
Q4 25
-265.2%
-18.8%
Q3 25
-329.4%
-14.2%
Q2 25
-474.6%
-18.5%
Q1 25
-903.4%
-43.4%
Q4 24
-11.1%
Q3 24
-1330.1%
-22.6%
Q2 24
-1662.4%
-22.7%
Q1 24
-205.0%
52.8%
EPS (diluted)
BOLT
BOLT
MDRR
MDRR
Q4 25
$-9.38
$-0.49
Q3 25
$-3.72
$-0.33
Q2 25
$-4.46
$-0.34
Q1 25
$-0.29
$-0.74
Q4 24
$-13.73
$-0.24
Q3 24
$-7.93
$-0.47
Q2 24
$-11.12
$-0.47
Q1 24
$-0.28
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOLT
BOLT
MDRR
MDRR
Cash + ST InvestmentsLiquidity on hand
$27.5M
$2.6M
Total DebtLower is stronger
$51.4M
Stockholders' EquityBook value
$26.5M
$9.4M
Total Assets
$56.7M
$77.7M
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOLT
BOLT
MDRR
MDRR
Q4 25
$27.5M
$2.6M
Q3 25
$31.9M
$1.9M
Q2 25
$34.8M
$2.0M
Q1 25
$38.8M
$2.7M
Q4 24
$47.3M
$4.8M
Q3 24
$53.8M
$3.1M
Q2 24
$73.7M
$3.8M
Q1 24
$91.3M
$3.6M
Total Debt
BOLT
BOLT
MDRR
MDRR
Q4 25
$51.4M
Q3 25
$63.6M
Q2 25
$49.6M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BOLT
BOLT
MDRR
MDRR
Q4 25
$26.5M
$9.4M
Q3 25
$32.1M
$10.4M
Q2 25
$38.8M
$13.4M
Q1 25
$46.8M
$14.0M
Q4 24
$57.2M
$15.0M
Q3 24
$72.0M
$12.6M
Q2 24
$85.9M
$13.2M
Q1 24
$104.2M
$13.7M
Total Assets
BOLT
BOLT
MDRR
MDRR
Q4 25
$56.7M
$77.7M
Q3 25
$65.1M
$92.1M
Q2 25
$75.5M
$77.7M
Q1 25
$85.9M
$78.2M
Q4 24
$99.6M
$75.1M
Q3 24
$109.3M
$74.6M
Q2 24
$124.2M
$75.2M
Q1 24
$142.9M
$76.0M
Debt / Equity
BOLT
BOLT
MDRR
MDRR
Q4 25
5.45×
Q3 25
6.13×
Q2 25
3.70×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOLT
BOLT
MDRR
MDRR
Operating Cash FlowLast quarter
$-7.2M
$1.5M
Free Cash FlowOCF − Capex
$77.0K
FCF MarginFCF / Revenue
2.7%
Capex IntensityCapex / Revenue
51.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOLT
BOLT
MDRR
MDRR
Q4 25
$-7.2M
$1.5M
Q3 25
$-9.7M
$1.6M
Q2 25
$-9.6M
$244.1K
Q1 25
$-13.4M
$460.0K
Q4 24
$-14.4M
$1.8M
Q3 24
$-14.0M
$139.9K
Q2 24
$-16.1M
$778.6K
Q1 24
$-16.8M
$492.4K
Free Cash Flow
BOLT
BOLT
MDRR
MDRR
Q4 25
$77.0K
Q3 25
$1000.0K
Q2 25
$-181.5K
Q1 25
$322.4K
Q4 24
$893.7K
Q3 24
$-14.0M
$-164.7K
Q2 24
$645.6K
Q1 24
$265.8K
FCF Margin
BOLT
BOLT
MDRR
MDRR
Q4 25
2.7%
Q3 25
35.9%
Q2 25
-7.4%
Q1 25
13.9%
Q4 24
35.4%
Q3 24
-1227.6%
-7.0%
Q2 24
28.1%
Q1 24
10.3%
Capex Intensity
BOLT
BOLT
MDRR
MDRR
Q4 25
51.5%
Q3 25
20.4%
Q2 25
17.3%
Q1 25
5.9%
Q4 24
35.7%
Q3 24
3.6%
13.0%
Q2 24
0.0%
5.8%
Q1 24
0.0%
8.8%
Cash Conversion
BOLT
BOLT
MDRR
MDRR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOLT
BOLT

Segment breakdown not available.

MDRR
MDRR

Retail Center Properties$1.6M58%
Other$1.2M42%

Related Comparisons